WO2007031727A3 - System for delivering neuronal calcium sensor - 1 (ncs - 1) - Google Patents
System for delivering neuronal calcium sensor - 1 (ncs - 1) Download PDFInfo
- Publication number
- WO2007031727A3 WO2007031727A3 PCT/GB2006/003367 GB2006003367W WO2007031727A3 WO 2007031727 A3 WO2007031727 A3 WO 2007031727A3 GB 2006003367 W GB2006003367 W GB 2006003367W WO 2007031727 A3 WO2007031727 A3 WO 2007031727A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ncs
- delivering
- calcium sensor
- neuronal calcium
- neuronal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4728—Calcium binding proteins, e.g. calmodulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15041—Use of virus, viral particle or viral elements as a vector
- C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15041—Use of virus, viral particle or viral elements as a vector
- C12N2740/15045—Special targeting system for viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
- C12N2810/6072—Vectors comprising as targeting moiety peptide derived from defined protein from viruses negative strand RNA viruses
- C12N2810/6081—Vectors comprising as targeting moiety peptide derived from defined protein from viruses negative strand RNA viruses rhabdoviridae, e.g. VSV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Marine Sciences & Fisheries (AREA)
- Immunology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention provides a system capable of delivering neuronal calcium sensor-1 (NCS-1), or a nucleotide sequence encoding NCS-1 to a target cell, for promoting neurite outgrowth. The system may be used in the manufacture of a pharmaceutical composition for the treatment of a condition such as spinal cord injury.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06779383A EP1937820A2 (en) | 2005-09-13 | 2006-09-11 | System for delivering neuronal calcium sensor-1 (ncs-1) |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0518674.7 | 2005-09-13 | ||
GB0518674A GB0518674D0 (en) | 2005-09-13 | 2005-09-13 | System |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007031727A2 WO2007031727A2 (en) | 2007-03-22 |
WO2007031727A3 true WO2007031727A3 (en) | 2008-05-15 |
Family
ID=35221413
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2006/003367 WO2007031727A2 (en) | 2005-09-13 | 2006-09-11 | System for delivering neuronal calcium sensor - 1 (ncs - 1) |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1937820A2 (en) |
GB (1) | GB0518674D0 (en) |
WO (1) | WO2007031727A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10639384B2 (en) | 2016-03-23 | 2020-05-05 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Targeting the neuronal calcium sensor 1 for treating wolfram syndrome |
CN112852976B (en) * | 2021-03-17 | 2023-10-31 | 湖北省农业科学院畜牧兽医研究所 | Molecular marker related to later egg laying characteristics in NCS1 gene of laying hen and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001075135A1 (en) * | 2000-03-30 | 2001-10-11 | Oxford Biomedica (Uk) Limited | Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders |
EP1250931A1 (en) * | 2001-04-17 | 2002-10-23 | F. Hoffmann-La Roche Ag | Novel use of neuronal calcium sensor-1 (NCS-1) in therapy of CNS disorders and in the development of therapeutic agents |
-
2005
- 2005-09-13 GB GB0518674A patent/GB0518674D0/en not_active Ceased
-
2006
- 2006-09-11 EP EP06779383A patent/EP1937820A2/en not_active Withdrawn
- 2006-09-11 WO PCT/GB2006/003367 patent/WO2007031727A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001075135A1 (en) * | 2000-03-30 | 2001-10-11 | Oxford Biomedica (Uk) Limited | Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders |
EP1250931A1 (en) * | 2001-04-17 | 2002-10-23 | F. Hoffmann-La Roche Ag | Novel use of neuronal calcium sensor-1 (NCS-1) in therapy of CNS disorders and in the development of therapeutic agents |
Non-Patent Citations (3)
Title |
---|
KAWASAKI T, ET AL.: "SPATIOTEMPORAL DISTRIBUTION OF NEURONAL CALCIUM SENSOR-1 IN THE DEVELOPING RAT SPINAL CORD", THE JOURNAL OF COMPARATIVE NEUROLOGY, vol. 460, 2003, pages 465 - 475, XP009076437 * |
NAKAMURA T Y, ET AL.: "NOVEL ROLE OF NEURONAL CA2+ SENSOR-1 AS A SURVIVAL FACTOR UP-REGULATED IN INJURED NEURONS", THE JOURNAL OF CELL BIOLOGY, vol. 172, no. 7, 27 March 2006 (2006-03-27), pages 1081 - 1091, XP002412312 * |
PAN C-Y, ET AL.: "ALTERATIONS IN EXOCYTOSIS INDUCED BY NEURONAL CA2+ SENSOR-1 IN BOVINE CHROMAFFIN CELLS", THE JOURNAL OF NEUROSCIENCE, vol. 22, no. 7, 2002, pages 2427 - 2433, XP002412311 * |
Also Published As
Publication number | Publication date |
---|---|
EP1937820A2 (en) | 2008-07-02 |
GB0518674D0 (en) | 2005-10-19 |
WO2007031727A2 (en) | 2007-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007006307A3 (en) | Novel salts of fumaric acid monoalkylesters and their pharmaceutical use | |
WO2007092496A3 (en) | 7,9-dihydro-purin-8-one and related analogs as hsp90-inhibitors | |
WO2007016538A3 (en) | Preparation and use of biphenyl amino acid derivatives for the treatment of obesity | |
WO2007068894A3 (en) | Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease | |
WO2006135915A3 (en) | Methods and compositions for treating degenerative bone disorders | |
WO2007025709A3 (en) | Organic compounds | |
WO2008127364A3 (en) | Antiviral compounds and use thereof | |
WO2008136865A3 (en) | (s)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs | |
WO2009149171A3 (en) | Fgf21 mutants and uses thereof | |
EP1140840A4 (en) | -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors | |
WO2007117657A3 (en) | Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency | |
WO2008065372A3 (en) | Modified erythropoietin polypeptides and uses thereof for treatment | |
WO2007120689A3 (en) | Methods of using gpr119 receptor to identify compounds useful for increasing bone mass in an individual | |
WO2008014307A3 (en) | Inhibitors of undecaprenyl pyrophosphate synthase | |
WO2007075439A3 (en) | Compositions and methods for treating obesity and related metabolic disorders | |
WO2010130830A3 (en) | Anti-sclerostin vhh and their use for treating bone diseases | |
WO2008066630A3 (en) | Methods for reprogramming adult somatic cells and uses thereof | |
WO2008064202A3 (en) | Modified-release formulations of calcium receptor-active compounds | |
WO2009062576A3 (en) | Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same | |
WO2007060213A3 (en) | Erythropoietin polypeptides and uses thereof | |
WO2008069876A3 (en) | Amidated dopamine neuron stimulating peptides for cns dopaminergic upregulation | |
WO2008109165A3 (en) | Mineralized guided bone regeneration membranes and methods of making the same | |
WO2009115252A3 (en) | Substituted pyrazolamides and the use thereof | |
WO2009047513A3 (en) | Antagonists of kisspeptin and uses thereof | |
EP1186672A3 (en) | Polymorphisms in the human organic anion transporter C (OATP-C) gene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006779383 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2006779383 Country of ref document: EP |